Published in Women's Health Weekly, October 21st, 2004
It remains unclear, though, which patients would most benefit from adjuvant chemotherapy and what the optimal treatment regimen would entail.
The findings come from an analytical review of data from 13 randomized control trials (RCTs), which will be published in the November 1, 2004, issue of Cancer. It was published online on September 27, 2004.
About one quarter of all ovarian cancers are caught while confined to the ovaries, when 5-year survival is...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.